Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinomaKazushi Numata, Katsuaki Tanaka, Hiroyuki Fukuda et al.|European Journal of Radiology|2013Cited by 38
Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver diseaseKazushi Numata, Katsuaki Tanaka, Hiroyuki Fukuda et al.|Abdominal Imaging|2015Cited by 36
Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.Satoshi Moriya, Katsuaki Tanaka, Manabu Morimoto et al.|PubMed|2013Cited by 25
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weightingMasaaki Kondo, Katsuaki Tanaka, Manabu Morimoto et al.|Journal of Digestive Diseases|2014Cited by 20
Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinomaFeiqian Wang, Shin Maeda, Kazushi Numata et al.|Quantitative Imaging in Medicine and Surgery|2021Cited by 15